test44
https://www.cytel.com/blog/an-interview-with-grammati-sarri-on-moderating-an-issue-panel-at-ispor-us-2022-0
May 5, 2022
While randomized control trials remain the industry gold-standard for regulatory and reimbursement submissions, there..
Read article
test44
https://www.cytel.com/blog/an-interview-with-gabriel-tremblay-on-his-poster-contributions-to-ispor-us-2022
April 29, 2022
At ISPOR US 2022, Cytel’s HEOR & RWE experts will be contributing to a range of Issue Panels, In-person Podium..
Read article
test44
https://www.cytel.com/blog/join-cytel-heor-consultants-at-ispor-us-2022
April 13, 2022
The Life Sciences landscape has seen an impactful digital evolution in the past two years. The pandemic has accelerated..
Read article
test44
https://www.cytel.com/blog/myths-surrounding-the-use-of-synthetic-control-arms-in-clinical-trials-part-1
June 10, 2021
Over the past decade, single arm trials have emerged as an accepted way of assessing a new treatment intervention...
Read article
test44
https://www.cytel.com/blog/advances-in-heor-an-interview-with-anna-forsythe
April 29, 2021
After twenty years in pharma, Anna Forsythe was frustrated by traditional vendors who used outdated methods to prepare..
Read article
test44
https://www.cytel.com/blog/adjusting-os-for-treatment-switch
April 13, 2016
We continue our series of blogs covering the expert presentations from the EAST User Group Meeting. Consultant Claire..
Read article